BclX_L (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury.

ABSTRACT:

SUBMITTER: Marola OJ 

PROVIDER: S-EPMC9307748 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature